International audienceBackground: Antibody responses as serological markers of Plasmodium vivax infection have been shown to correlate with exposure, but little is known about the other factors that affect antibody responses in naturally infected people from endemic settings. To address this question, we studied IgG responses to novel serological exposure markers (SEMs) of P. vivax in three settings with different transmission intensity.Methodology: We validated a panel of 34 SEMs in a Peruvian cohort with up to three years’ longitudinal follow-up using a multiplex platform and compared results to data from cohorts in Thailand and Brazil. Linear regression models were used to characterize the association between antibody responses and age, ...
Plasmodium vivax remains a global health problem and its ability to cause relapses and subpatent inf...
Plasmodium vivax remains a global health problem and its ability to cause relapses and subpatent inf...
Abstract Background Thailand is aiming to eliminate malaria by the year 2024. Plasmodium vivax has n...
International audienceBackground: Antibody responses as serological markers of Plasmodium vivax infe...
BackgroundAntibody responses as serological markers of Plasmodium vivax infection have been shown to...
Plasmodium vivax remains an important cause of malaria in South America and the Asia-Pacific. Natura...
BACKGROUND: Identifying Plasmodium vivax antigen-specific antibodies associated with P. vivax infect...
Plasmodium vivax remains an important cause of malaria in South America and the Asia-Pacific. Natura...
BACKGROUND: Thailand is aiming to eliminate malaria by the year 2024. Plasmodium viv...
Abstract To achieve malaria elimination, new tools are required to explicitly target Plasmodium viva...
Plasmodium vivax remains an important cause of malaria in South America and the Asia-Pacific. Natura...
Plasmodium vivax remains an important cause of malaria in South America and the Asi...
Plasmodium vivax remains an important cause of malaria in South America and the Asia...
Thailand is aiming for malaria elimination by the year 2030. However, the high proportion of asympto...
To achieve malaria elimination, new tools are required to explicitly target Plasmodium vivax. Recent...
Plasmodium vivax remains a global health problem and its ability to cause relapses and subpatent inf...
Plasmodium vivax remains a global health problem and its ability to cause relapses and subpatent inf...
Abstract Background Thailand is aiming to eliminate malaria by the year 2024. Plasmodium vivax has n...
International audienceBackground: Antibody responses as serological markers of Plasmodium vivax infe...
BackgroundAntibody responses as serological markers of Plasmodium vivax infection have been shown to...
Plasmodium vivax remains an important cause of malaria in South America and the Asia-Pacific. Natura...
BACKGROUND: Identifying Plasmodium vivax antigen-specific antibodies associated with P. vivax infect...
Plasmodium vivax remains an important cause of malaria in South America and the Asia-Pacific. Natura...
BACKGROUND: Thailand is aiming to eliminate malaria by the year 2024. Plasmodium viv...
Abstract To achieve malaria elimination, new tools are required to explicitly target Plasmodium viva...
Plasmodium vivax remains an important cause of malaria in South America and the Asia-Pacific. Natura...
Plasmodium vivax remains an important cause of malaria in South America and the Asi...
Plasmodium vivax remains an important cause of malaria in South America and the Asia...
Thailand is aiming for malaria elimination by the year 2030. However, the high proportion of asympto...
To achieve malaria elimination, new tools are required to explicitly target Plasmodium vivax. Recent...
Plasmodium vivax remains a global health problem and its ability to cause relapses and subpatent inf...
Plasmodium vivax remains a global health problem and its ability to cause relapses and subpatent inf...
Abstract Background Thailand is aiming to eliminate malaria by the year 2024. Plasmodium vivax has n...